You are here:Home1/News Release2/EISAI ENTERS INTO JOINT DEVELOPMENT AGREEMENT WITH BLISSBIO FOR ANTIBODY DRUG CONJUGATE BB-1701 WITH OPTION RIGHTS FOR STRATEGIC COLLABORATION
/wordpress/wp-content/uploads/2021/04/logo3.png00赵, 丰/wordpress/wp-content/uploads/2021/04/logo3.png赵, 丰2023-05-08 11:19:112023-05-10 11:19:59EISAI ENTERS INTO JOINT DEVELOPMENT AGREEMENT WITH BLISSBIO FOR ANTIBODY DRUG CONJUGATE BB-1701 WITH OPTION RIGHTS FOR STRATEGIC COLLABORATION